TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
187,664
|
168,913
|
135,631 |
| Earnings before taxes |
12,700
|
7,832
|
6,914 |
| Total assets |
43,295
|
31,358
|
33,604 |
| Current assets |
43,086
|
30,937
|
32,973 |
| Current liabilities |
11,087
|
8,909
|
4,594 |
| Equity capital |
32,183
|
22,356
|
28,871 |
| - share capital |
268
|
269
|
269 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.3%
|
71.3%
|
85.9% |
| Turnover per employee |
26,809
|
24,130
|
19,376 |
| Profit as a percentage of turnover |
6.8%
|
4.6%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
388.6%
|
347.3%
|
717.7% |
| Return on equity (ROE) |
39.5%
|
35.0%
|
23.9% |
| Change turnover |
19,127
|
33,281
|
32,328 |
| Change turnover % |
11%
|
25%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.